Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Evia Bio logo — Better and Safer Therapeutics Enabled by All-Natural Cryopre...

Evia Bio

Better and Safer Therapeutics Enabled by All-Natural Cryopreservation.

Founded 2019 United States Minneapolis, United States 11 employees Private Equity Total: $260.00K Biotechnology, Health and Wellness +1

General Information

Company Name Evia Bio
Founded Year 2019
Location United States Minneapolis, United States +1
Employees 11
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Private Equity
Social

Get notified when Evia Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Evia Bio

Evia Bio is a biotechnology startup founded in 2019 and headquartered in the United States. The company's slogan, "Better and Safer Therapeutics Enabled by All-Natural Cryopreservation," reflects its commitment to developing innovative solutions for the growing cell therapy market. Evia Bio collaborates with cell therapy companies to advance products to clinical trials and commercialization by providing non-DMSO cryopreservation solutions developed by cryobiologist Allison Hubel, PhD. The solutions employ all-natural organic compounds to safeguard cell integrity during cryopreservation and ensure patient safety at the point of care. Evia Bio's approach to cryopreservation offers a promising alternative to traditional methods, potentially unlocking the full potential of life-saving therapies. The company recently secured a Private Equity Round investment on 01 January 2024, with the investment coming from Pleasant Bay Capital Partners. This injection of funding signifies external validation of Evia Bio's potential and could propel the company towards further growth and impact in the biotechnology and cell therapy sectors. For more information, please visit www.eviabio.com.

Taxonomy: Life Science Innovation, Cell Therapy, Cryopreservation, Therapeutics, Clinical Trials, Commercialization, Biopharmaceuticals, Organic Compounds, Cell Integrity, Patient Safety, Gene Therapy, Biomedical Research, Bioengineering, Medical Innovations

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round •••••• 1
Investor
01 Jan 2024
Grant •••••• 1 •••• •••• 06 Dec 2022
Series A •••••• 1 •••• •••• 30 Jun 2022

Evia Bio Alternatives & Competitors

Evia Bio vs
Cell Matters
Cell Matters

Enhancing cell therapy productivity with advanced cryopreservation solutions and GMP-compliant servi...

Series A
Biotechnology, Health and Wellness
Evia Bio vs
Nkarta, Inc.
Nkarta, Inc. United States

A New Way Forward for Autoimmune Disease

Post Ipo Equity
157 employees
Biotechnology, Health Care
Evia Bio vs
CaseBioscience
CaseBioscience

Your trusted partner for the development & manufacturing of high quality solutions for the cell ther...

9 employees
Biotechnology, Health Care

FAQ About Evia Bio

Better and Safer Therapeutics Enabled by All-Natural Cryopreservation.
Evia Bio was founded in 2019.
Evia Bio is headquartered in Minneapolis, United States.
Evia Bio operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
Evia Bio has approximately 11 employees.
Evia Bio has completed 3 funding rounds, raising a total of $260.00K. The latest funding stage is Private Equity.
Top alternatives and competitors to Evia Bio include Cell Matters, Nkarta, Inc., CaseBioscience, Stem Med Pte Ltd, Wilson Wolf Manufacturing, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Evia Bio and Cell Matters are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Evia Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy